| Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306) |
|---|
| 01/18/2005 | CA2333686C Method and device for electrochemical immunoassay of multiple analytes |
| 01/13/2005 | WO2004086039A3 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 01/13/2005 | US20050010029 Using nucleotide sequence cleavage, rearrangement and ligation to generate novel protein libraries for as tool in evaluating and screening drugs; peptide mimetics; directed evolution of proteins |
| 01/11/2005 | US6841661 Glycopeptide antibacterial compounds, compositions containing same and methods of using same |
| 01/11/2005 | US6841532 Peptides and their use to ameliorate cell death |
| 01/06/2005 | WO2005000873A1 Preparation of glycosylated amino acids, proteins and peptides via olefin metathesis reactions |
| 01/05/2005 | EP1493747A1 Process for producing modified peptide |
| 12/30/2004 | US20040266666 Cross-linked glycopeptide-cephalosporin antibiotics |
| 12/29/2004 | WO2004113350A1 Cross-linked glycopeptide - cephalosporin antibiotics |
| 12/23/2004 | WO2004111192A2 Targeted delivery to legumain-expressing cells |
| 12/23/2004 | US20040260069 Modified anti-tnf aplha antibody |
| 12/23/2004 | CA2536357A1 Targeted delivery to legumain-expressing cells |
| 12/22/2004 | EP1487863A2 Process for purifying glycopeptide phospohonate derivatives |
| 12/14/2004 | US6831150 Combining an aldehyde or ketone, base, the glycopeptide, acidifying the reaction mixture and combining with a reducing agent to alkylate the glycopeptide at the saccharide amine; glycopeptide antibiotics |
| 12/09/2004 | US20040247610 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations |
| 12/08/2004 | EP1483286A1 A process for the production of ramoplanin-like amide derivatives |
| 12/08/2004 | CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA |
| 12/02/2004 | US20040242467 Contacting an aqueous solution of the lipopeptide antibiotic and a divalent metal ion with an organic solvent, thereby extracting the lipopeptide antibiotic into the organic solvent; andcontacting the organic solvent extract of the lipopeptide antibiotic with acid |
| 11/25/2004 | US20040235735 Gene expression of cells; genetic engineering using tripeptides; antiinflammatory agents; apoptosis;medical diagnosis |
| 11/18/2004 | WO2004099231A2 Glycopegylation methods and proteins/peptides produced by the methods |
| 11/18/2004 | WO2004099135A2 Hiv prodrugs cleavable by cd26 |
| 11/18/2004 | WO2004098644A1 Prodrugs cleavable by cd26 |
| 11/18/2004 | US20040229775 Bactericide drug |
| 11/18/2004 | CA2525191A1 Prodrugs cleavable by cd26 |
| 11/18/2004 | CA2522345A1 Glycopegylation methods and proteins/peptides produced by the methods |
| 11/18/2004 | CA2517338A1 Hiv prodrugs cleavable by cd26 |
| 11/17/2004 | CN1547481A Process for preparing glycopeptide phosphonate derivatives |
| 11/16/2004 | US6818201 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis |
| 11/11/2004 | WO2004096836A1 Novel glycopeptide or peptide capable of imparting rich taste and method of imparting rich taste to food therewith |
| 11/04/2004 | WO2004094590A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 11/04/2004 | WO2004086039A8 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 11/04/2004 | CA2522904A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 11/03/2004 | EP1472277A1 Fap-activated anti-tumor compounds |
| 10/28/2004 | WO2004091552A2 Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
| 10/28/2004 | US20040214228 Selecting glycoproteins with enhanced activities for use as diagnostic tools in disease diagnosis; glycomics; proteomics |
| 10/28/2004 | CA2521718A1 Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
| 10/27/2004 | EP1470141A2 Glycosulfopeptide inhibitors and methods of use thereof |
| 10/27/2004 | EP1418933A4 Process for preparing glycopeptide phosphonate derivatives |
| 10/26/2004 | CA1341461C T helper cell growth factor |
| 10/21/2004 | WO2004090154A2 Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis |
| 10/21/2004 | WO2004044222A3 Polymeric prodrugs of vancomycin |
| 10/21/2004 | US20040208884 Administering construct in conjugated or unconjugated form and in combination with immunogenic carrier to induce antibodies; anticarcinogenic agents |
| 10/21/2004 | CA2521130A1 Acyl-phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis |
| 10/14/2004 | WO2004087730A2 Method for producing diverse libraries of encoded polymers |
| 10/14/2004 | US20040204346 Intermediate for preparing glycopeptide derivatives |
| 10/14/2004 | US20040203090 Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
| 10/07/2004 | WO2004086039A2 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 10/07/2004 | WO2004069873A3 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 10/07/2004 | WO2003018608A3 Process for purifying glycopeptide phosphonate derivatives |
| 10/07/2004 | CA2520662A1 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 10/05/2004 | US6800608 Homogeneous assay of vancomycin using a stable particle-vancomycin conjugate, a novel rate enhancer, and a novel dose response modulator |
| 09/30/2004 | WO2004083807A2 Methods of evaluating glycomolecules for enhanced activities |
| 09/30/2004 | CA2516814A1 Methods of evaluating glycomolecules for enhanced activities |
| 09/29/2004 | EP1461445A2 Glycoprotein remodeling using endoglycanases |
| 09/29/2004 | EP1461444A2 Glycopeptide remodeling using amidases |
| 09/16/2004 | WO2004078781A1 Protein-binding doxorubicin peptide derivatives |
| 09/16/2004 | DE10310082A1 Protein-bindende Doxorubicin-Peptid-Derivate Protein-binding doxorubicin-peptide derivatives |
| 09/14/2004 | CA2136438C Anthracycline conjugates, their preparation and their use as antitumor agents |
| 09/10/2004 | WO2004076476A1 Glycopeptide and use thereof as proteoglycan initiator |
| 09/10/2004 | WO2004075843A2 Glycosolated enkephalin agents |
| 09/10/2004 | CA2507527A1 Glycosolated enkephalin agents |
| 09/02/2004 | US20040171523 Immunogenic glycopeptides, screening, preparation and uses |
| 08/31/2004 | US6783931 Amine-derivatized nucleosides and oligonucleosides |
| 08/25/2004 | EP1448602A2 Modified anti-tnf alpha antibody |
| 08/25/2004 | EP0836619B1 Purification of dalbaheptide antibiotics by isoelectric focusing |
| 08/19/2004 | WO2004069873A2 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 08/19/2004 | CA2514270A1 Antigen/antibody or ligand/receptor glycosylated specificity exchangers |
| 08/12/2004 | US20040158035 Substantially pure glycopeptide antibiotics AC-98-1, AC-98-2, AC-98-3, AC-98-4 and AC-98-5 |
| 08/05/2004 | WO2004064784A2 Composition and method for preventing or treating a virus infection |
| 08/05/2004 | WO2003072058A3 Dna-binding polyamide drug conjugates |
| 08/05/2004 | CA2511570A1 Composition and method for preventing or treating a virus infection |
| 08/04/2004 | EP0981542B1 20(s) camptothecin glycoconjugates |
| 08/03/2004 | US6770621 Polyacid glycopeptide derivatives |
| 07/22/2004 | WO2004044224A3 Branched polymeric prodrugs of vancomycin |
| 07/22/2004 | WO2004044223A3 Prodrugs of vancomycin with hydrolysis resistant polymer linkers |
| 07/22/2004 | WO2004019970A3 Glycopeptide antibiotic and semisynthetic derivatives thereof and their use as antiviral agents |
| 07/22/2004 | US20040142858 Prodrugs of vancomycin with hydrolysis resistant polymer linkages |
| 07/22/2004 | US20040142857 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| 07/22/2004 | US20040142856 Glycoconjugation methods and proteins/peptides produced by the methods |
| 07/22/2004 | US20040142355 Methods, compositions and libraries pertaining to PNA dimer and PNA oligomer synthesis |
| 07/15/2004 | US20040138411 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 07/15/2004 | US20040138106 Glycoprotein synthesis |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040137469 Peptide Nucleic Acids (PNA); an acid forming cleavable linker and a PNA dimer comprising an N-terminal base labile protecting group, cleavably linked to the solid support through the cleavable linker |
| 07/15/2004 | US20040136947 Polymeric prodrugs of vancomycin |
| 07/14/2004 | EP1435974A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 07/14/2004 | EP0730601B1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 07/07/2004 | EP1434779A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 07/01/2004 | WO2004000802A3 Scaffolded maleimide clusters for multivalent peptide assembly |
| 07/01/2004 | US20040126838 Cell-free, in vitro method of remodeling a (FSH) peptide by deglycosylating and then contacting the truncated glycan with at least one glycosyltransferase and at least one glycosyl donor; improved properties, for its use as a therapeutic agent |
| 06/24/2004 | WO2004026894A3 Synthesis and characterization of novel systems for guidance and vectorization of compounds having a therapeutic activity |
| 06/24/2004 | US20040121958 Methods of alleviating neuropathic pain |
| 06/17/2004 | US20040116334 Useful as anti-bacterial agents |
| 06/17/2004 | US20040115168 cell-free, in vitro method of ataching a specific glycan structure; treating multiple sclerosis |
| 06/15/2004 | US6750199 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| 06/10/2004 | US20040110665 Oligopeptide antibiotics with leucine and sugars for treating infectionswith polypeptides. |
| 06/03/2004 | US20040106785 Inhibitors of RNA dependent RNA polymerase and uses thereof |
| 06/03/2004 | US20040106772 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 06/03/2004 | US20040106544 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements |
| 05/27/2004 | WO2004044224A2 Branched polymeric prodrugs of vancomycin |